Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Current-Deferred-Revenue" stands at 0.127 Billion United States Dollars as of 12/31/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.59 percent compared to the value the year prior.
The 1 year change in percent is 29.59.
The 3 year change in percent is 3.25.
The 5 year change in percent is 11.40.
The 10 year change in percent is -61.40.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |